No CrossRef data available.
Article contents
Litigation and the toxicity of psychotropic drugs: A reply to Prof Patricia Casey
Published online by Cambridge University Press: 13 June 2014
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Letters to the Editor
- Information
- Copyright
- Copyright © Cambridge University Press 1996
References
1.Leonard, BE. Editorial: Litigation and the toxicity of psychotropic drugs. Ir J Psychol Med 1996; 13:88–9CrossRefGoogle Scholar
2.Casey, P. Commentary: Litigation and the toxicity of psychotropic drugs. Ir J Psychol Med 1996; 13:89–90CrossRefGoogle Scholar
3.Carlston, A, Allebeck, P, Brandt, L. Are suicide rates in Sweden associated with changes in the prescribing of medicines? Acta Psychiat Scand 1996; 94: 94–100.CrossRefGoogle Scholar
5.Henry, JA, Alexander, CA, Sener, EK. Relative mortality from overdose of antidepressives. BMJ 1995; 310: 221–4.CrossRefGoogle Scholar
6.Daly, RJ. Medico-legal aspects of prescribing. Human Psychopharmac 1994; 9(1):S31–S36.CrossRefGoogle Scholar
7.de Gier, JJ. Drugs other than alcohol and driving in the European Union. Study coordinated with the support of the European Blood Safety Federation and the Directorate General for Transport of the Commission for the European Communities. EC document 1995; IHP: 95–94.Google Scholar
8.Ray, WA, Fought, RL, Decker, MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 1992; 16: 873–83.CrossRefGoogle Scholar
9.Montgomery, SA, Henry, JA, McDonald, G, et al.Selective serotonin re-uptake inhibitors: meta analysis of discontinuation rates. Int Clin Psychopharmac 1994; 9: 47–53.CrossRefGoogle Scholar
You have
Access